Universal Health Services, Inc. (UHS)
- Previous Close
184.16 - Open
184.01 - Bid --
- Ask --
- Day's Range
181.06 - 187.56 - 52 Week Range
153.99 - 243.25 - Volume
773,749 - Avg. Volume
954,926 - Market Cap (intraday)
12.166B - Beta (5Y Monthly) 1.30
- PE Ratio (TTM)
10.48 - EPS (TTM)
17.80 - Earnings Date Jul 22, 2025 - Jul 28, 2025
- Forward Dividend & Yield 0.80 (0.43%)
- Ex-Dividend Date Mar 3, 2025
- 1y Target Est
223.90
Universal Health Services, Inc., through its subsidiaries, owns and operates acute care hospitals, and outpatient and behavioral health care facilities. It operates through Acute Care Hospital Services and Behavioral Health Care Services segments. The company's hospitals offer general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic and coronary care, pediatric, pharmacy, and/or behavioral health services. It also provides commercial health insurance services; and various management services, including central purchasing, information services, finance and control systems, facilities planning, physician recruitment, administrative personnel management, marketing, and public relations services. The company was founded in 1978 and is headquartered in King of Prussia, Pennsylvania.
uhs.com99,300
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: UHS
View MorePerformance Overview: UHS
Trailing total returns as of 5/7/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: UHS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: UHS
View MoreValuation Measures
Market Cap
12.17B
Enterprise Value
17.13B
Trailing P/E
10.48
Forward P/E
9.85
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.78
Price/Book (mrq)
1.79
Enterprise Value/Revenue
1.07
Enterprise Value/EBITDA
7.31
Financial Highlights
Profitability and Income Statement
Profit Margin
7.44%
Return on Assets (ttm)
7.57%
Return on Equity (ttm)
18.47%
Revenue (ttm)
16.08B
Net Income Avi to Common (ttm)
1.2B
Diluted EPS (ttm)
17.80
Balance Sheet and Cash Flow
Total Cash (mrq)
126.75M
Total Debt/Equity (mrq)
73.98%
Levered Free Cash Flow (ttm)
849.64M